“…The objective of this study was to synthesize flavonoid acetamide derivatives and evaluate their bioavailability, antioxidant, and ADMET properties. The flavonoid acetamide derivatives in this study are: 2,2′,2′′-((2-(3,4-bis(2-amino-2-oxoethoxy)phenyl)-4-oxo-4 H -chromene-3,5,7-triyl)tris(oxy))triacetamide (1S3); 2 2,2′-((2-(4-(2-amino-2-oxoethoxy)phenyl)-4-oxo-4 H -chromene-5,7-diyl)bis(oxy))diacetamide (2S3); 2 2,2′-((4-(3,7-bis(2-amino-2-oxoethoxy)-4-oxo-4 H -chromen-2-yl)-1,2-phenylene)bis(oxy))diacetamide (3S3); 2,2′,2′′-((2-(4-(2-amino-2-oxoethoxy)phenyl)-4-oxo-4 H -chromene-3,5,7-triyl)tris(oxy))triacetamide (4S3) and 2,2′-((4-(5,7-bis(2-amino-2-oxoethoxy)-4-oxo-4 H -chromen-2-yl)-1,2-phenylene)bis(oxy))diacetamide (5S3). The antioxidant capacity was evaluated using the DPPH· radical assay; in vitro bioavailability was determined using the dialysis tubing procedure while the ADMET properties of these compounds were determined using computational tools.…”